| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/21/2004 | CN1146424C Stabilized tibolone compositions |
| 04/21/2004 | CN1146423C Prostaglandin product |
| 04/21/2004 | CN1146419C Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants |
| 04/21/2004 | CN1146418C Fixed-dose association of angiotensin-converting enzyme inhibitor and of calcium channel antagonist, method for preparation and use thereof in treatment of cardivas cular illnesses |
| 04/21/2004 | CN1146417C Stabilized pharmaceutical compositions, with quinupristine and dalfopristine base and their prepn |
| 04/21/2004 | CN1146413C Pharmaceutical composition for injection based on paracetamol |
| 04/21/2004 | CN1146410C Controlled release formulation |
| 04/21/2004 | CN1146409C Fast decomposing pellets |
| 04/21/2004 | CN1146408C Novel poly(methylidene malonate) microspheres, preparation method and pharmaceutical compositions containing them |
| 04/21/2004 | CN1146407C Stable shaped particles of crystalline organic compounds |
| 04/21/2004 | CN1146406C Composition comprising finely divided, crystalling particles of budesnoide |
| 04/21/2004 | CN1146405C Free-flowing dried particles |
| 04/21/2004 | CN1146404C Opthalmic solution comprising glycogen |
| 04/21/2004 | CN1146403C Active substance releasing system |
| 04/21/2004 | CN1146402C Gel composition and method of preparing the composition |
| 04/21/2004 | CN1146401C Bioadhensive solid dosage form |
| 04/20/2004 | US6723814 Amphiphilic copolymer planar membranes |
| 04/20/2004 | US6723781 Blend of crosslinked acrylic acid polymers or copolymers and and a high molecular weight essentially linear acrylic acid copolymer; good tack and adhesion; transdermal delivery |
| 04/20/2004 | US6723748 Vision disorders; topical applying |
| 04/20/2004 | US6723737 Methods, pharmaceutical and therapeutic compostions for administering adenosine |
| 04/20/2004 | US6723732 Percutaneously adminstrable preparations containing cerebral function activators |
| 04/20/2004 | US6723714 Aqueous solvent for corticosteroids |
| 04/20/2004 | US6723713 Use of mometasone furoate for treating upper airway diseases |
| 04/20/2004 | US6723708 Lithium chloride |
| 04/20/2004 | US6723703 Administering powder or aerosol to nasal mucosa and osteomeatal complex |
| 04/20/2004 | US6723372 Spraying grains which consist of a prostane derivative and a cyclodextrin vehicle, forming together a prostane-cyclodextrine-clathrate, with an aqueous polymer dispersion of ethyl cellulose and/or poly(methyl)acrylic acid ester |
| 04/20/2004 | US6723363 Coating foods and pharmaceuticals with an edible polymer using carbon dioxide |
| 04/20/2004 | US6723358 Encapsulation of components into edible products |
| 04/20/2004 | US6723353 Preserved cyclodextrin-containing compositions |
| 04/20/2004 | US6723350 Powder of one or more antimicrobial metals formed with atomic disorder; coating becomes antimicrobial and anti-inflammatory when wet. |
| 04/20/2004 | US6723348 Orodispersible tablets containing fexofenadine |
| 04/20/2004 | US6723347 Freezing a protein-containing solution at a cooling rate of about -300 to -10 degrees c./min. and then drying; atomizing to produce fine powder |
| 04/20/2004 | US6723346 Flowable, non-dusty, and binder-free riboflavin granulates can be manufactured from a mixture of riboflavin crystals of modification b and c |
| 04/20/2004 | US6723345 Topical drug preparations |
| 04/20/2004 | US6723343 Pharmaceutical tramadol salts |
| 04/20/2004 | US6723342 Edible coating composition |
| 04/20/2004 | US6723341 Antibiotic product, use and formulation thereof |
| 04/20/2004 | US6723340 Optimal polymer mixtures for gastric retentive tablets |
| 04/20/2004 | US6723339 Hard gelatine capsule |
| 04/20/2004 | US6723338 Liposome- encapsulated vinca alkaloids are unusually effective in the treatment of a variety of forms of lymphoma especially relapsed forms of non-hodgkin's lymphoma |
| 04/20/2004 | US6723337 Non-aqueous acrylic polymer, superior adhesion and durability instead of water-soluble polymer significantly decreases thickness of patch; non-ionic surfactant and terpene are used as absorption enhancers; dissolution assistant is used |
| 04/20/2004 | US6723335 Methods and compositions for treating intervertebral disc degeneration |
| 04/20/2004 | US6723326 Topical compositions containing probiotic Bacillus bacteria, spores, and extracellular products and uses thereof |
| 04/20/2004 | US6723170 Controlling supersaturation, elongated crystal structure, can be easily separated and dried |
| 04/20/2004 | US6723086 Remote controlled transdermal medication delivery device |
| 04/20/2004 | US6722780 Preparation of liquid dispersions |
| 04/20/2004 | CA2421976C Medicaments |
| 04/20/2004 | CA2247405C Slow-release pharmaceutical formulations containing mizolastin |
| 04/20/2004 | CA2208539C The production of divisible tablets |
| 04/20/2004 | CA2191204C Formulation preparation device |
| 04/20/2004 | CA2172265C Transdermal delivery device containing an estrogen |
| 04/20/2004 | CA2125408C Drug formulations for parenteral use |
| 04/20/2004 | CA2122344C Liposome preparation containing tricyclic compound |
| 04/20/2004 | CA2102778C Novel compositions based on taxane class derivatives |
| 04/20/2004 | CA2087420C Ophthalmic pharmaceutical composition containing n-acetyl-cisteine and polyvinylalcohol |
| 04/20/2004 | CA2054822C Formulations and their use in the treatment of neurological diseases |
| 04/20/2004 | CA2044593C Method of in vivo delivery of functioning foreign genes |
| 04/17/2004 | CA2444781A1 Topical gel matrix |
| 04/15/2004 | WO2004031581A2 Electroactive polymer actuated medication infusion pumps |
| 04/15/2004 | WO2004030803A1 Granulation system and process for producing powder using granulation system |
| 04/15/2004 | WO2004030743A2 Drug delivery device having coated microprojections incorporating vasoconstrictors |
| 04/15/2004 | WO2004030724A2 Methods and systems for providing orthogonally redundant monitoring in a sedation and analgesia system |
| 04/15/2004 | WO2004030714A1 Patch |
| 04/15/2004 | WO2004030700A1 Solid preparation |
| 04/15/2004 | WO2004030691A1 Sustained release preparation containing nk4 |
| 04/15/2004 | WO2004030675A1 17β-ESTRADIOL/LEVONORGESTREL TRANSDERM PATCH FOR HORMONE REPLACEMENT THERAPY |
| 04/15/2004 | WO2004030673A1 Antibacterial medicinal composition of enhanced oral absorptivity |
| 04/15/2004 | WO2004030670A1 Potent inhibitor of hcv serine protease |
| 04/15/2004 | WO2004030667A1 Nasal drop composition |
| 04/15/2004 | WO2004030665A1 Transparent gel composition, for the administration of diclofenac sodium through the skin |
| 04/15/2004 | WO2004030661A2 Therapeutic compositions comprising a boron-containing compound |
| 04/15/2004 | WO2004030659A1 Sustained release porous microparticles for inhalation |
| 04/15/2004 | WO2004030658A1 Enteric composition for the manufacture of soft capsule wall |
| 04/15/2004 | WO2004030657A1 Spheroids, preparation method thereof and pharmaceutical compositions |
| 04/15/2004 | WO2004030655A1 Inorganic shaped bodies and methods for their production and use |
| 04/15/2004 | WO2004030653A1 Compositions for preventing posterior capsular opacification and the use thereof |
| 04/15/2004 | WO2004030652A2 Dosage form having an inner core and at least two coating layers |
| 04/15/2004 | WO2004030651A2 Method, compounds and preparations for the identification of sentinel lymph nodes |
| 04/15/2004 | WO2004030650A2 Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
| 04/15/2004 | WO2004030649A2 Methods for producing and stabilising microsuspensions and nanosuspensions by means of amphiphiles and polyelectrolytes |
| 04/15/2004 | WO2004030648A1 Fast releasing, solid administration form for oral application of active ingredients which are hard to dissolve |
| 04/15/2004 | WO2004030647A2 Target-oriented formulations |
| 04/15/2004 | WO2004030623A2 Nitroxide radioprotector formulations and methods of use |
| 04/15/2004 | WO2004030608A2 Nanoemulsion vaccines |
| 04/15/2004 | WO2004030457A1 Nodulisporic acid derivative spot-on formulations for combating parasites |
| 04/15/2004 | WO2004017962A3 Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region |
| 04/15/2004 | WO2004014446A9 Embolization |
| 04/15/2004 | WO2004012720A8 Process for making orally consumable dosage forms |
| 04/15/2004 | WO2004012665A3 Composition and methods for the treatment of musculoskeletal disorders and collagen and elastin deficiencies |
| 04/15/2004 | WO2004004689A8 Compositions and methods for amelioration of human female sexual dysfunction |
| 04/15/2004 | WO2004002398A3 Spherical pellet containing a water-soluble active ingredient |
| 04/15/2004 | WO2003103588A3 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 04/15/2004 | WO2003103581A3 Compositions and methods for liver growth and liver protection |
| 04/15/2004 | WO2003092655A3 Use of active ingredient mixtures with azelaic acids and glycyrrhetic acids as anti-acne agents |
| 04/15/2004 | WO2003086471A3 Lyophilized and liquid preparations comprising a polysaccharide derivative of camptothecin |
| 04/15/2004 | WO2003080554A3 Iodinated triglyceride analogs |
| 04/15/2004 | WO2003077888A3 Compressed tablets comprising microcapsules with modified release |
| 04/15/2004 | WO2003061555A3 West nile vaccine |
| 04/15/2004 | WO2003049717A3 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases |
| 04/15/2004 | WO2003039615A3 Porous polymeric prostheses and methods for making same |